Pedro F. S. Freitas, MD
@Freitas_PedroFS
📍 SUO Fellow & Clinical Instructor @dsui_miami_uro 😷 Residency @Urologia_USP 🎓 MD @unb_oficial Urologic Oncology & robotics. Views my own
Happy to have contributed to the latest @ElsevierConnect Hinman’s Atlas of Urologic Surgery! Huge shoutout to @KhandekarArchan for his fantastic work putting it all together— a rising star in our field. Excited to see all the great things he’ll do!
⚠️ Check out our latest paper on genomics in the Miami Active Surveillance Trial (MAST): 🔹️ Genomic scores were similar between GG1 cores with vs. without GG2+ cancer elsewhere in the prostate. 🔹️PCa is multifocal and each focus is genomically independent. @sanojpunnen
Dr. Freitas et al. share their thoughts on the recent article, “Can Genomic classifiers in biopsy cores with Grade Group 1 cancer predict higher-grade disease elsewhere in the prostate?..." Read the full article here! ➡️ bit.ly/44UAtzQ @Freitas_PedroFS
Join us in celebrating @gonzomdphd, M.D., Ph.D., M.B.A., as he steps into his new role as Chair of the Department of Urology @dsui_miami_uro and @umiamimedicine! 🩺 A nationally recognized leader in urologic care, research, and education, Dr. Gonzalgo will oversee and lead…
We’re proud to share that the University of Miami Board of Trustees has unanimously endorsed Dr. Dipen J. Parekh (@dipenjparekh) as the next Chief Executive Officer of UHealth and Executive Vice President for Health Affairs at the University of Miami (@univmiami). UHealth and…
Shared three posters at the #aua2025 this year. Early steps in our homegrown AI efforts at @dsui_miami_uro. Built by our team, with real clinical problems in mind. More to come. #codetoclinic
#AUA2025 Excited to have presented on genomic data gathered for 10yrs. in the Miami Active Surveillance Trial (MAST) ran by @sanojpunnen at @dsui_miami_uro. ⚠️ GG1 cancer foci are independent - genomic scores do not predict higher-grade disease elsewhere in the prostate!


Had a fantastic time at the 2025 @dsui_miami_uro Miami Symposium of Human Metabolism! Insightful discussions on the intersections of metabolism, aging, and cancer from experts across the country and overseas. And great opportunity to meet friends from @NimaSharifiMD Lab!

Happy 100th birthday @univmiami! The future is in the next generation of physicians we train. The future is in the unrivaled patient care we provide. The future is in medical research that saves lives. The future is at UHealth. The future is at The Miller School of Medicine. The…
A momentous birthday: The U turns 100! Let’s celebrate together at 100.miami.edu or read more: bit.ly/4jLoYAo #UMiami100 #umiami
Representing @dsui_miami_uro at the Miami Half Marathon! Thank you @KhandekarArchan for the partnership and support in and outside the hospital! #MiamiHalfMarathon

Great weekend with @dsui_miami_uro on the beach 🏝️
It's been truly exciting, Dr. @NimaSharifiMD ! The OR definitely brings unique research opportunities.
Pedro Freitas brings so much energy, enthusiasm, innovation and fun - to OR to bench translational studies! There is so much to look forward to! @Freitas_PedroFS @dsui_miami_uro
Sharing our translational projects at #DSUIonthebeach25 - with the ultimate goal of bridging the gap between the operating room and @NimaSharifiMD's Lab for transformative discoveries!

We are thrilled to have our urologic oncologists at the #SUO2025 annual conference! An incredible opportunity to learn, network, and share insights with peers dedicated to advancing care for patients. 💡🤝 #UrologyInnovation @UroOnc @chadritchmd
The adrenal-permissive HSD3B1 variant is present in up to 50% of prostate cancer patients! Honored to work with @AlirezaAbdshah , @DrRanaMcKay and @NimaSharifiMD on updating the evidence on this prognostic marker that may allow for precision therapies! nature.com/articles/s4158…
I am delighted that our updated Perspectives on HSD3B1 in prostate cancer is out @NatRevUrol! Many thanks to @Freitas_PedroFS @AlirezaAbdshah and @DrRanaMcKay! @dsui_miami_uro @SylvesterCancer @UCSDCancer @PCF_Science rdcu.be/d0dPL
Accuracy of warm ischemia time measurement using a surgical intelligence software in partial #nephrectomies: A validation study @KhandekarArchan @dsui_miami_uro @dipenjparekh @joaogsporto doi.org/10.1002/bco2.4…